Opdivo/Yervoy Combination Fares Well in Lung Cancer Immunotherapy TrialP&T CommunityPositive results have been reported from a crucial immunotherapy trial that used a combination of two Bristol-Myers Squibb (BMS) drugs, nivolumab (Opdivo) and ipilimuma… Continue reading
Idaho Press-Tribune |
St. Luke’s Mountain States Tumor Institute designated a stem cell or blood and marrow donor site
Idaho Press-Tribune BOISE — St. Luke’s Mountain States Tumor Institute in Boise announced this week it is the first site in Idaho that can collect stem cell or blood and marrow donations, and one donor has already saved a life through the institute, according to a press … |
Houston Business Journal |
Texas A&M, Celltex Therapeutics to research Alzheimer’s therapies …
Houston Business Journal Houston-based Celltex Therapeutics Corp. and Texas A&M University Health Science Center College of Medicine Institute for Regenerative Medicine have entered into a multiyear agreement for research into potential Alzheimer’s therapies. The research will … |
Phys.Org |
New CRISPR method efficiently corrects DMD defect in heart tissue
Phys.Org Dr. Eric Olson shows DMD patient Ben Dupree the dystrophin protein (red) produced in gene-edited heart muscle cells taken from Mr. Dupree’s blood. A new study from Dr. Olson shows the CRISPR-Cas9 gene-editing tool can potentially correct a …more … Cut and Paste: How China is Exploring Human Genome EditingSputnik International Novel method can edit genes with substantially fewer errorsBrinkwire (press release) |